KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) EBT (2016 - 2025)

Historic EBT for Lam Research (LRCX) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Lam Research's EBT rose 3623.25% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.0 billion, marking a year-over-year increase of 4338.51%. This contributed to the annual value of $6.0 billion for FY2025, which is 3664.74% up from last year.
  • Lam Research's EBT amounted to $1.8 billion in Q4 2025, which was up 3623.25% from $1.9 billion recorded in Q3 2025.
  • Over the past 5 years, Lam Research's EBT peaked at $1.9 billion during Q3 2025, and registered a low of $863.6 million during Q2 2023.
  • In the last 5 years, Lam Research's EBT had a median value of $1.3 billion in 2021 and averaged $1.3 billion.
  • As far as peak fluctuations go, Lam Research's EBT surged by 8427.28% in 2021, and later tumbled by 3801.88% in 2023.
  • Quarter analysis of 5 years shows Lam Research's EBT stood at $1.4 billion in 2021, then rose by 21.81% to $1.7 billion in 2022, then crashed by 34.2% to $1.1 billion in 2023, then rose by 24.02% to $1.3 billion in 2024, then skyrocketed by 36.23% to $1.8 billion in 2025.
  • Its EBT was $1.8 billion in Q4 2025, compared to $1.9 billion in Q3 2025 and $1.8 billion in Q2 2025.